Indication
Biallelic RPE65 mutation-associated retinal dystrophy
Biallelic RPE65 mutation-associated retinal dystrophy is a rare, severe inherited retinal disease characterized by pathogenic variants in both alleles of the *RPE65* gene. Read more about Biallelic RPE65 mutation-associated retinal dystrophy
1 drugs 1 manufacturers
Drugs that treat it
Common Biallelic RPE65 mutation-associated retinal dystrophy therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBiallelic RPE65 mutation-associated retinal dystrophy is a rare, severe inherited retinal disease characterized by pathogenic variants in both alleles of the *RPE65* gene.
This genetic defect disrupts the visual cycle in the retinal pigment epithelium by impairing the isomerohydrolase enzyme needed to convert all-*trans*-retinyl esters into 11-*cis*-retinal, ultimately causing progressive photoreceptor degeneration.
Clinically encompassing phenotypes such as Leber congenital amaurosis and early-onset retinitis pigmentosa, it primarily presents in infancy or early childhood with severe nyctalopia, nystagmus, and constricted visual fields.
Over time, affected individuals experience progressive peripheral and central vision loss, which typically leads to complete blindness as viable retinal tissue deteriorates.
- nih.gov
Biallelic RPE65 mutation-associated retinal dystrophy is a rare, severe inherited retinal disease characterized by pathogenic variants in both alleles of the *RPE65* gene
- nih.gov
Biallelic RPE65 mutation-associated retinal dystrophy is a rare, severe inherited retinal disease characterized by pathogenic variants in both alleles of the *RPE65* gene This genetic defect disrupts the visual cycle in the retinal pigment epithelium by impairing the isomerohydrolase enzyme needed to convert all-*trans*-retinyl esters into 11-*cis*-retinal, ultimately causing progressive photoreceptor degeneration Clinically encompassing phenotypes such as Leber congenital amaurosis and early-on...
- fda.gov
This genetic defect disrupts the visual cycle in the retinal pigment epithelium by impairing the isomerohydrolase enzyme needed to convert all-*trans*-retinyl esters into 11-*cis*-retinal, ultimately causing progressive photoreceptor degeneration
- bcbsms.com
This genetic defect disrupts the visual cycle in the retinal pigment epithelium by impairing the isomerohydrolase enzyme needed to convert all-*trans*-retinyl esters into 11-*cis*-retinal, ultimately causing progressive photoreceptor degeneration Over time, affected individuals experience progressive peripheral and central vision loss, which typically leads to complete blindness as viable retinal tissue deteriorates
- nih.gov
Clinically encompassing phenotypes such as Leber congenital amaurosis and early-onset retinitis pigmentosa, it primarily presents in infancy or early childhood with severe nyctalopia, nystagmus, and constricted visual fields
- araceagainstblindness.org
Clinically encompassing phenotypes such as Leber congenital amaurosis and early-onset retinitis pigmentosa, it primarily presents in infancy or early childhood with severe nyctalopia, nystagmus, and constricted visual fields
Personalize your experience
Follow Biallelic RPE65 mutation-associated retinal dystrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.